-

Specialist CRO Welcomes Dr Juan Gabriel Ovalles Bonilla as Medical Rheumatology Lead

MONTREAL--(BUSINESS WIRE)--Innovaderm Research, one of the world’s leading specialist CROs in dermatology, has announced the appointment of the seasoned Europe-based board-certified rheumatologist Dr Juan Gabriel Ovalles Bonilla to its team. Dr Ovalles’ experience and expertise marks Innovaderm’s expansion into rheumatology, reflecting its recognition of the need for a dedicated CRO in this specialty, and its commitment to advancing research and patient care in all systemic autoimmune diseases.

Dr Ovalles brings over 12+ years of clinical research experience and an unrivaled background in both general and pediatric rheumatology to Innovaderm, adding to the company’s robust clinical, drug development, regulatory, medical knowledge and capabilities, particularly in rheumatology. He is a distinguished member of the Spanish Society of Rheumatology, and his expertise spans systemic immune-mediated diseases, inflammatory arthropathies, juvenile rheumatic conditions, crystal-deposition diseases, osteoarthritis and osteoporosis.

Dr Ovalles said: “I am delighted to be joining the knowledgeable and skillful team at Innovaderm. With so many clear commonalities between dermatology and rheumatology, the company is well positioned to lead the way in rheumatology research and already has long-standing relationships with key physicians and clinical trial leaders in Europe, North America, LATAM and APAC. I look forward to sharing our experiences and expertise across these closely linked disciplines and applying our joint capabilities to groundbreaking research projects in both fields.”

For more information about our rheumatology resources please visit: https://innovaderm.com/rheumatology/

Innovaderm Research Inc.
Innovaderm Research Inc. is a specialized CRO with a dual focus on dermatology and rheumatology. We assist biopharmaceutical sponsors in initiating and completing clinical trials in all phases of development. With over 25 years of globally recognized expertise in dermatology clinical trial execution, an extensive and continually expanding network of clinicians and sites, and a dedicated research clinic, Innovaderm offers a highly informed, focused, and comprehensive approach to addressing niche clinical needs in dermatology and now rheumatology.

Contacts

For more information:
Valerie Coveney
Communications Specialist
Innovaderm Research Inc.
vcoveney@innovaderm.com

Innovaderm Research Inc.



Contacts

For more information:
Valerie Coveney
Communications Specialist
Innovaderm Research Inc.
vcoveney@innovaderm.com

More News From Innovaderm Research Inc.

Indero Named Best Employer by Mercer

MONTREAL--(BUSINESS WIRE)--Indero, a global CRO specializing in dermatology and rheumatology, has been honored by Mercer, recognizing its excellence as a Best Employer. Indero is proud of its long-term commitment to building a workplace culture defined by trust, fairness, and meaningful employee experiences and believes this distinction reflects its positive impact in 2025. The Best Employers in Canada – Powered by Mercer certification program recognizes organizations that consistently deliver...

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

MONTREAL--(BUSINESS WIRE)--Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated and led the study, shared his excitement about the results: “Our g...

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

MONTREAL--(BUSINESS WIRE)--Indero, the niche CRO formerly known as Innovaderm, is celebrating 25 years of advancing clinical research. From its roots as a dermatology site in Montreal, Indero has grown into a global organization with capabilities in more than 30 countries across 4 continents and has earned a reputation for delivering expert, efficient trials in dermatology and, more recently, rheumatology. Indero was founded as Innovaderm in 2000, starting as a clinical site and now a global CR...
Back to Newsroom